| Latest | F'cast | |
|---|---|---|
| Div Yield | 1.8% | |
| Div Cover | 3.4 | |
| Op Mrgn | 16.3% | |
| ROCE | 21.7% |
| Latest | F'cast | |
|---|---|---|
| P/E | 16.4 | |
| PEG | 0.1 | |
| Pr/Revenue | 5.2 | |
| Pr/Book | 4.5 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 4.6% | |
| PBT | 5.2% | |
| EPS | 133.8% | |
| DPS | 7.7% |
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-20 | 34,608.00 | 4,968.00 | 252.00¢ | 43.4 | 2.0 | +22% | 153.00¢ | 1.4% |
| 31-Dec-21 | 43,075.00 | 8,211.00 | 4.01¢ | 3,512.1 | n/a | -98% | 1.84¢ | 0.0% |
| 31-Dec-22 | 43,653.00 | 8,306.00 | 394.00¢ | 27.9 | 0.0 | +9,732% | 192.00¢ | 1.7% |
| 31-Dec-23 | 40,109.00 | 6,664.00 | 328.00¢ | 33.6 | n/a | -17% | 208.00¢ | 1.9% |
| 31-Dec-24 | 41,950.00 | 7,013.00 | 767.00¢ | 14.7 | 0.1 | +134% | 224.00¢ | 2.0% |
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-25 | 44,669.81 | 10,327.73 | 515.30¢ | 24.4 | n/a | -33% | 231.06¢ | 0.0% |
| 31-Dec-26 | 48,107.89 | 11,455.24 | 567.58¢ | 22.2 | 2.2 | +10% | 252.07¢ | 0.0% |
| 31-Dec-27 | 51,660.02 | 12,597.90 | 629.38¢ | 20.0 | 1.8 | +11% | 259.26¢ | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
| Coronavirus 99%-accurate antibody test approved ... | 29-Apr-2020 | ShareCast |
| Answer to whether Covid-19 antibodies confer imm... | 23-Apr-2020 | ShareCast |
| Currency | US Dollars |
| Share Price | $ 125.80 |
| Closing Price Change | $ 1.96 |
| % Change | 0.00 % |
| 52 Week High | $140.22 |
| 52 Week Low | $111.10 |
| Volume | 0 |
| Shares Issued | 1,731.70m |
| Beta | 0.25 |
| RiskGrade | 113 |
| Strong Buy | 11 |
| Buy | 9 |
| Neutral | 8 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 28 |

You are here: research